Finally, the strength of AFP-L3 and DCP in predicting multiple HCC outcomes in studies thus far could eventually lead to updated guidelines for HCC liver transplant candidate selection, allocation of extended criteria liver donors, and post-transplant surveillance and adjuvant therapy protocols. Here, AFP is linked to hepatocellular carcinoma.